A detailed history of Abbot Financial Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Abbot Financial Management, Inc. holds 4,037 shares of NVO stock, worth $343,145. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,037
Previous 3,609 11.86%
Holding current value
$343,145
Previous $515,000 6.8%
% of portfolio
0.25%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $50,961 - $62,239
428 Added 11.86%
4,037 $480,000
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $442,860 - $530,198
3,609 New
3,609 $515,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Abbot Financial Management, Inc. Portfolio

Follow Abbot Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abbot Financial Management, Inc. with notifications on news.